Gregory Johnson is a research scientist at EvolutionaryScale and the co-founder of NewLimit, a therapeutics company focused on epigenetic reprogramming. Holding a Ph. D. from Carnegie Mellon University, his expertise lies in machine learning and generative models. Colleagues describe him as a top-skilled scientist with exceptional technical depth and ownership.
He co-invented a 3D label-free microscopy method during his time at the Allen Institute for Cell Science.
Read the full overview →
Experience
14 Years
Current Role
Research
Location
San Francisco, California, United States
Personality Overview
How Gregory shows up
Not Easily Convinced
Cautious & Analytical
Systematic
They prefer to do thorough analysis of any situation. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. It is quite likely of them to ask for pricing or other concessions.
Priorities
Topics Gregory cares about
AI in Biology
His career is dedicated to the intersection of AI and biology, from developing generative models for cell science to his current research at EvolutionaryScale.
Extending Healthspan
He co-founded NewLimit, a company with the mission of using epigenetic reprogramming to radically extend human healthspan.
+5 more topicsLogin to view topics
Career
Work history
3-2025
Research
EvolutionaryScale
3-2022 - 10-2024
Co-founder & Head of Machine Learning
NewLimit
3-2020 - 3-2022
Sr. Applied Machine Learning Scientist
Amazon
2-2016 - 3-2020
Scientist -> Scientist II -> Sr. Scientist
Allen Institute for Cell Science
6-2012 - 1-2016
PhD Student
Carnegie Mellon University
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.